Pura Flor D Isleta’s research while affiliated with National Institutes of Health and other places

The evoked otoacoustic emission (EOAE) test is a universally well-known and established procedure for screening the hearing of babies during the newborn period. It has been documented in foreign literature that the prevalence of hearing loss is significantly higher in high-risk neonates. In the Philippine General Hospital, 301 high-risk neonates and 105 non high-risk neonates were screened for hearing loss using the EOAE during a period of one year from March 2000 to March 2001. The initial failure rate in the high-risk population was 33% and 11% in the non high-risk population.